Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.

Autophagy modulators corneal autophagy inflammation ocular surface dry eye disease

Journal

Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376

Informations de publication

Date de publication:
04 2023
Historique:
medline: 10 4 2023
entrez: 7 4 2023
pubmed: 8 4 2023
Statut: ppublish

Résumé

Dry eye disease (DED) is a chronic ocular surface disorder, associated with inflammation, which can cause severe morbidity, visual compromise, and loss of quality of life, affecting up to 5-50% of the world population. In DED, ocular surface damage and tear film instability due to abnormal tear secretion lead to ocular surface pain, discomfort, and epithelial barrier disruption. Studies have shown the involvement of autophagy regulation in dry eye disease as a pathogenic mechanism along with the inflammatory response. Autophagy is a self-degradation pathway in mammalian cells that reduces the excessive inflammation driven by the secretion of inflammatory factors in tears. Specific autophagy modulators are already available for the management of DED currently. However, growing studies on autophagy regulation in DED might further encourage the development of autophagy modulating drugs that reduce the pathological response at the ocular surface. In this review, we summarize the role of autophagy in the pathogenesis of dry eye disease and explore its therapeutic application.

Identifiants

pubmed: 37026260
pii: IndianJOphthalmol_2023_71_4_1285_373509
doi: 10.4103/IJO.IJO_2912_22
pmc: PMC10276742
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1285-1291

Déclaration de conflit d'intérêts

None

Références

Expert Opin Pharmacother. 2017 Oct;18(14):1517-1524
pubmed: 28841079
Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82
pubmed: 25686388
Ocul Surf. 2019 Oct;17(4):699-713
pubmed: 31412290
Biomed Res Int. 2014;2014:292139
pubmed: 24995283
Biomed Res Int. 2018 Nov 1;2018:7627329
pubmed: 30519584
Nat Rev Immunol. 2016 Nov;16(11):661-675
pubmed: 27694913
Antioxid Redox Signal. 2014 Jan 20;20(3):460-73
pubmed: 23725295
Ocul Surf. 2017 Jul;15(3):575-628
pubmed: 28736343
Nature. 2008 Nov 13;456(7219):264-8
pubmed: 18849965
Front Med (Lausanne). 2021 Dec 14;8:799949
pubmed: 34970573
Invest Ophthalmol Vis Sci. 2019 Sep 3;60(12):3708-3716
pubmed: 31479110
Autophagy. 2012 Jul 1;8(7):1146-7
pubmed: 22627195
J Biol Chem. 2013 Jun 21;288(25):18146-61
pubmed: 23640897
J Innate Immun. 2013;5(5):427-33
pubmed: 23774579
Int J Biol Sci. 2016 Jun 07;12(7):884-97
pubmed: 27313501
Int J Mol Sci. 2020 Nov 26;21(23):
pubmed: 33255884
Inflamm Bowel Dis. 2017 Feb;23(2):224-232
pubmed: 27997434
J Ocul Pharmacol Ther. 2021 Sep;37(7):386-393
pubmed: 34227851
J Ocul Pharmacol Ther. 2022 Jun;38(5):331-338
pubmed: 35613408
J Cell Sci. 2020 Sep 9;133(17):
pubmed: 32907930
Exp Eye Res. 2016 Mar;144:1-3
pubmed: 26348132
Food Chem Toxicol. 2018 Aug;118:889-907
pubmed: 29960018
Clin Transl Med. 2017 Dec;6(1):24
pubmed: 28748360
J Biol Chem. 2021 Jan-Jun;296:100070
pubmed: 33187980
Clin Ophthalmol. 2017 Apr 24;11:773-779
pubmed: 28479849
Cell Res. 2014 Jan;24(1):24-41
pubmed: 24366339
Cell Mol Life Sci. 2015 Dec;72(24):4721-57
pubmed: 26390974
Nat Rev Mol Cell Biol. 2018 Jun;19(6):365-381
pubmed: 29626215
Exp Eye Res. 2021 Apr;205:108491
pubmed: 33587908
Ocul Surf. 2017 Jul;15(3):539-574
pubmed: 28736342
Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C73-C87
pubmed: 27413169
Prog Retin Eye Res. 2016 Nov;55:206-245
pubmed: 27566190
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):2836-2847
pubmed: 31266058
Exp Eye Res. 2007 May;84(5):894-904
pubmed: 17362931
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3286-3293
pubmed: 29971448
Cell Death Dis. 2014 Jun 26;5:e1309
pubmed: 24967971
Mol Cell Biochem. 2020 Nov;474(1-2):41-55
pubmed: 32710189
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2609-14
pubmed: 12147592
Nature. 2011 Jan 20;469(7330):323-35
pubmed: 21248839
Ocul Surf. 2017 Jul;15(3):276-283
pubmed: 28736335
Cell Mol Life Sci. 2012 Apr;69(7):1125-36
pubmed: 22080117
Exp Eye Res. 2019 Jul;184:126-134
pubmed: 31018117
PLoS One. 2011 Apr 07;6(4):e18666
pubmed: 21490934
Sci Rep. 2017 Dec 8;7(1):17280
pubmed: 29222450
Exp Eye Res. 2006 May;82(5):885-98
pubmed: 16309672
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):372-385
pubmed: 28122086
Ocul Surf. 2013 Oct;11(4):246-58
pubmed: 24112228
Acta Ophthalmol. 2018 Jun;96(4):e412-e420
pubmed: 28834388
Cont Lens Anterior Eye. 2013 Dec;36(6):272-80
pubmed: 23928365
Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):26
pubmed: 32785678
Nat Cell Biol. 2010 Sep;12(9):863-75
pubmed: 20711182
Front Immunol. 2022 Sep 20;13:949206
pubmed: 36203590
Exp Eye Res. 2020 Nov;200:108210
pubmed: 32896533

Auteurs

Nallathambi Jeyabalan (N)

GROW Research Laboratory, Narayana Nethralaya Foundation, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India.

Aswathi M Pillai (AM)

GROW Research Laboratory, Narayana Nethralaya Foundation, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India.

Pooja Khamar (P)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.

Rohit Shetty (R)

Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.

Rajiv R Mohan (RR)

Harry S. Truman Memorial Veterans' Hospital; Departments of Veterinary Medicine and Surgery and Biomedical Sciences, University of Missouri; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, USA.

Arkasubhra Ghosh (A)

GROW Research Laboratory, Narayana Nethralaya Foundation, Narayana Nethralaya Eye Hospital, Bengaluru, Karnataka, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH